A Multicenter Randomized Controlled Trial of Best Available Therapy versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis

Protocol No

NEURO-ITN-077I-BEAT-MS

Staff Member

Ahmed Obeidat

Phase

III

Summary

This project is being done to compare high dose immunosuppression (lower the body's immune system and its ability to fight infections and other diseases) followed by autologous hematopoietic stem cell transplantation (AHSCT) to best available therapy (BAT) in relapsing MS

Objective

Best Available Therapy vs Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis

Study Sites

Froedtert Hospital

Status

OPEN TO ACCRUAL